Related Experiment Video
Updated: Jun 12, 2025
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
Longer-Term Effects of SARS-CoV-2 Infection on Asthma Exacerbation
Kevin E Duong1, Sonya S Henry1, Michael D Cabana2
1Department of Radiology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
Background:
The long-term impact of COVID-19 on asthma exacerbations remains unclear.
Objective:
We assessed the future risk of asthma exacerbations after SARS-CoV-2 infection in pediatric and adult patients with asthma.
Methods:
We conducted a retrospective cohort study of 12,719 patients with asthma with SARS-CoV-2 infection (confirmed by polymerase chain reaction test) and 91,763 without recorded SARS-CoV-2 infection in a large urban health care system (March 1, 2020 to December 31, 2023). After matching for observation time, age, race, and ethnicity, 1,898 children and 8,532 adults were included in each group (with and without COVID-19). Andersen-Gill models adjusted for covariates (eg, allergic rhinitis, gastroesophageal reflux disease, eczema, obesity, unmet social needs) were used to calculate adjusted hazard ratios (aHRs) and 95% CIs for recurrent asthma exacerbations.
Results:
Children who were both hospitalized and not hospitalized for COVID-19 with preexisting asthma had higher exacerbation rates than controls (40.68% and 24.81%, respectively vs 14.70%; P < .001) and increased risk of future exacerbations (aHR = 3.29 [95% CI, 2.27-4.76]; aHR = 1.82 [95% CI, 1.51-2.21]); P < .001). Adults also showed increased asthma exacerbation rates in hospitalized (23.13%) and non-hospitalized (21.49%) individuals compared with controls (10.68%; P < .001). Similarly, adults who were both hospitalized and not hospitalized for COVID-19 had increased risk of future exacerbations (aHR = 2.78 [95% CI, 2.29-3.38]; aHR = 2.13 [95% CI, 1.73-2.62]). Overall, children faced higher risks than adults. Unmet social needs elevated the risk of future exacerbation in children (aHR = 1.36 [95% CI, 1.00-1.86]) and adults (aHR = 1.26 [95% CI, 1.04-1.52]).
Conclusions:
SARS-CoV-2 infection was associated with a higher cumulative incidence of asthma exacerbations. Patients with unmet social needs were at higher risk of exacerbation. Clinicians should prioritize preventive strategies, trigger reduction, and immunizations for patients with a history of asthma and SARS-CoV-2 infection.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Related Concept Videos
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:29Asthma-I: Introduction
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation